At a market cap of HK$9.5 billion and 5% dividend yield, Consun Pharmaceutical Group has gone through a long rally over the last 12 months. This has raised its shares from less than HK$3 to over HK$11… Credit: Google Finance What’s driving this dividend payer share price? Let’s find out. Background: What is Consun Pharmaceutical Group? Consun is a kidney-focused pharmaceutical company. Its crown jewel is a traditional Chinese medicine called Uremic Clearance Granules, or UCG. Credit: Company’s financial presentation Now, UCG isn’t a new discovery. It was first developed by China’s military hospitals back in the 1980s. Later on, when the Chinese government banned the military from running businesses, UCG was handed over to the private sector. This eventually became Consun’s core product. For patients who have chronic kidney disease, doctors offer dialysis as a solution to slow down the process. However, when the disease goes to later stages, the more frequently patients need to go to the hospitals....